Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab

AIMS: Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed the impact of baseline triglycerides on non-high-density lipoprotein cholesterol goal attainment in 10 phase 3 trials with alirocumab versus control (n = 4983). METHODS: Trials we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Prev Cardiol
Main Authors: Vallejo-Vaz, Antonio J, Leiter, Lawrence A, Del Prato, Stefano, Taskinen, Marja-Riitta, Müller-Wieland, Dirk, Bujas-Bobanovic, Maja, Letierce, Alexia, Mandel, Jonas, Samuel, Rita, Ray, Kausik K
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Full Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7549294/
https://ncbi.nlm.nih.gov/pubmed/32089006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487320905185
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados